Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Open Orphan plc    VENN   GB00B9275X97

OPEN ORPHAN PLC

(VENN)
  Report
Delayed Quote. Delayed London Stock Exchange - 11/25 11:35:18 am
24.1 GBX   -0.62%
03/16OPEN ORPHAN : Publication of positive results in journal ● ●
PU
03/16OPEN ORPHAN : Publication of positive results in journal
PU
03/12OPEN ORPHAN : Holding(s) in Company ●
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
11/19/2020 11/20/2020 11/23/2020 11/24/2020 11/25/2020 Date
23.5(c) 25.2(c) 24.8(c) 24.25(c) 24.1 Last
2 442 187 1 962 455 2 032 343 2 049 638 1 294 228 Volume
-3.09% +7.23% -1.59% -2.22% -0.62% Change
More quotes
Financials
Sales 2020 24,6 M 29,3 M 29,3 M
Net income 2020 -8,20 M -9,77 M -9,77 M
Net cash position 2020 10,9 M 13,0 M 13,0 M
P/E ratio 2020 39,6x
Yield 2020 -
Sales 2021 43,9 M 52,3 M 52,3 M
Net income 2021 7,00 M 8,34 M 8,34 M
Net cash position 2021 17,1 M 20,4 M 20,4 M
P/E ratio 2021 4,53x
Yield 2021 -
Capitalization 161 M 215 M 192 M
EV / Sales 2020 6,09x
EV / Sales 2021 3,28x
Nbr of Employees 132
Free-Float 76,6%
More Financials
Company
Open Orphan plc specializes in contracted research and development services for pharmaceutical and biotech companies, medical device manufacturers and academic organizations. The activity is organized around 2 areas: - research and drug preclinical and clinical development services; - clinical trial management services. 
More about the company
Notations Surperformance© of Open Orphan plc
Trading Rating : Investor Rating :
More Ratings
All news about OPEN ORPHAN PLC
03/16OPEN ORPHAN : Publication of positive results in journal ● ●
PU
03/16OPEN ORPHAN : Publication of positive results in journal
PU
03/12OPEN ORPHAN : Holding(s) in Company ●
PU
03/10OPEN ORPHAN : Publication of Positive Results in Journal ●
PU
03/09OPEN ORPHAN : Completion of Compulsory Acquisition of Shares ● ●
PU
03/09OPEN ORPHAN : Completion of Compulsory Acquisition of Shares
PU
03/09OPEN ORPHAN : Coronavirus Challenge Study Model
PU
03/06OPEN ORPHAN : New Contract ● ●
PU
03/06OPEN ORPHAN : New Contract
PU
03/02OPEN ORPHAN : Change in Registered Office
PU
02/27OPEN ORPHAN : Appointment of new Director ● ●
PU
02/27OPEN ORPHAN : Appointment of new Director
PU
02/21OPEN ORPHAN : Investor Event Attendance and Presentation
PU
02/20OPEN ORPHAN : Appointment of Chair of Advisory Board
PU
02/13OPEN ORPHAN : Appointment of Group Chief Financial Officer ●
PU
More news
News in other languages on OPEN ORPHAN PLC

- No features available -

More news
Chart OPEN ORPHAN PLC
Duration : Period :
Open Orphan plc Technical Analysis Chart | VENN | GB00B9275X97 | MarketScreener
Technical analysis trends OPEN ORPHAN PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 3
Average target price 0,33 €
Last Close Price 0,24 €
Spread / Highest target 47,2%
Spread / Average Target 37,6%
Spread / Lowest Target 28,1%
EPS Revisions
Managers
NameTitle
Cathal Martin Friel Executive Chairman
Timothy Sharpington Chief Operating Officer
Leo Toole Chief Financial Officer & Director
Andrew Catchpole Chief Scientist
Brendan Buckley Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
OPEN ORPHAN PLC432.97%216
LONZA GROUP AG56.17%44 950
MODERNA, INC.403.89%39 001
CELLTRION, INC.82.32%36 284
IQVIA HOLDINGS INC.11.32%32 977
SEAGEN INC.44.80%29 684